Skip to main content

Peer Review reports

From: High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study

Original Submission
24 Jul 2023 Submitted Original manuscript
25 Sep 2023 Reviewed Reviewer Report
7 Oct 2023 Reviewed Reviewer Report - Miguel Oliveira Santos
12 Oct 2023 Author responded Author comments - Alain Créange
Resubmission - Version 2
12 Oct 2023 Submitted Manuscript version 2
13 Oct 2023 Author responded Author comments - Alain Créange
Resubmission - Version 3
13 Oct 2023 Submitted Manuscript version 3
16 Oct 2023 Author responded Author comments - Alain Créange
Resubmission - Version 4
16 Oct 2023 Submitted Manuscript version 4
16 Oct 2023 Author responded Author comments - Alain Créange
Resubmission - Version 5
16 Oct 2023 Submitted Manuscript version 5
17 Oct 2023 Author responded Author comments - Alain Créange
Resubmission - Version 6
17 Oct 2023 Submitted Manuscript version 6
Publishing
18 Oct 2023 Editorially accepted
30 Oct 2023 Article published 10.1186/s12883-023-03440-y

You can find further information about peer review here.

Back to article page